tepotinib,osimertinib
merck,astrazeneca
['tepotinib', 'osimertinib', 'insight2']
tepotinib + osimertinib in metamp pos (acquired resistance post 1l osi) orr 43.9%- insight2 interim data #asco23 
Medical Oncologist, Tan Tock Seng Hospital Singapore with subspecialty interests in thoracic and GU oncology